Fresenius Medical Care, a leading global provider of products and services for individuals with renal diseases, is headquartered in the United States. Founded in 1996, the company has established a strong presence in North America, Europe, and Asia, focusing on dialysis services and the manufacture of dialysis equipment. With a commitment to innovation, Fresenius Medical Care offers a comprehensive range of products, including dialysis machines and consumables, which are distinguished by their advanced technology and patient-centric design. The company is recognised for its significant market position, serving millions of patients worldwide and achieving notable milestones in improving patient outcomes. As a key player in the healthcare industry, Fresenius Medical Care continues to lead in the development of integrated care solutions, enhancing the quality of life for those affected by chronic kidney disease.
How does Fresenius Medical Care's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Fresenius Medical Care's score of 67 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Fresenius Medical Care reported total carbon emissions of approximately 3,680,827,000 kg CO2e. This figure includes 360,803,000 kg CO2e from Scope 1 (direct emissions) and 326,636,000 kg CO2e from Scope 2 (indirect emissions related to energy use). The majority of their emissions, about 2,993,388,000 kg CO2e, fall under Scope 3, which encompasses emissions from the entire value chain, including purchased goods and services, employee commuting, and the use of sold products. Fresenius Medical Care has set ambitious climate commitments, aiming to reduce its Scope 1 and Scope 2 emissions by 50% by 2030, compared to 2020 levels. This target reflects their commitment to sustainability and aligns with industry standards for reducing greenhouse gas emissions. Additionally, the company has committed to achieving net-zero emissions across all scopes by 2050, demonstrating a long-term dedication to addressing climate change. In 2023, the company reported total emissions of approximately 3,958,000,000 kg CO2e, indicating a slight decrease in emissions from the previous year. Their ongoing efforts to monitor and reduce emissions are crucial in the healthcare sector, where sustainability practices are increasingly important.
Access structured emissions data, company-specific emission factors, and source documents
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|
Scope 1 | 218,700,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | 557,200,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Fresenius Medical Care is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.